pharma · Minimal Residual Disease · Pancreatic Ductal Adenocarcinoma · ELTX
Elicio Therapeutics
Elicio Therapeutics patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Boston, USA HQ
47 Employees
Public company Type
ELTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 47
- Programs
- 2
- Drugs
- 0
- Patents
- 4
Elicio Therapeutics patents
4 pharmaceutical patents indexed for Elicio Therapeutics. 0 expire within 24 months.
Elicio Therapeutics has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Elicio Therapeutics have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Elicio Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.